Clinical Trial: A Clinical Risk Score to Stratify High-risk PanNETs
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Pancreatic Neuroendocrine Tumors
Study Type: OBSERVATIONAL
Official Title: A Clinically Applicable Risk Score for Identifying High-risk Pancreatic Neuroendocrine Tumors: Development, Validation, and Biological Correlates
Brief Summary:
Considerable heterogeneity exists in the risk of recurrence after curative resection of pancreatic neuroendocrine tumors (PanNETs). Current clinicopathological parameters (e.g., grade, TNM stage) have limited capacity for individualized risk stratification. There is an urgent need for a clinically accessible and operationally simple predictive tools to identify high-risk PanNETs for optimizing personalized postoperative treatment and follow-up strategies. This study aims to identify risk factors associated with…
Read more